C. Oréar

Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment

Pitter F. Huesgen, R. Hollingsworth, C. Overall, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease

S. Richard, B. Teh, P. Dessen, 2018, International journal of oncology.

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.

A. Vekhoff, E. Solary, C. Preudhomme, 2011, Blood.

Integrated molecular portrait of non-small cell lung cancers

Pierre Validire, Philippe Dessen, Joakim Lundeberg, 2013, BMC Medical Genomics.

MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array

N. Rioux-Leclercq, J. Patard, J. Bernhard, 2014, Clinical Cancer Research.

Cisplatin resistance associated with PARP hyperactivation.

L. Galluzzi, O. Kepp, G. Kroemer, 2013, Cancer research.

Clonal architecture of chronic myelomonocytic leukemias.

E. Solary, W. Vainchenker, O. Bernard, 2013, Blood.

Assessment of Whole Genome Amplification for Sequence Capture and Massively Parallel Sequencing

Pierre Validire, Joakim Lundeberg, Mikael Huss, 2014, PloS one.

Direct and indirect CeO2 nanoparticles toxicity for Escherichia coli and Synechocystis

J. Rose, M. Auffan, N. Menguy, 2009 .

Iron Overload Exacerbates Busulfan-Melphalan Toxicity Through a Pharmacodynamic Interaction in Mice

P. Opolon, A. Paci, G. Vassal, 2016, Pharmaceutical Research.

Validation of whole genome amplification for analysis of the p53 tumor suppressor gene in limited amounts of tumor samples.

M. Huss, P. Zając, J. Lundeberg, 2012, Biochemical and biophysical research communications.

Clonal architecture of chronic myelomonocytic leukemias.

E. Solary, W. Vainchenker, O. Bernard, 2013, Blood.